drugset / Trial / NCT00002905
Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with HIV-related non-Hodgkin's lymphoma that has relapsed or has not responded to chemotherapy.
Timeline
- Start
- 1995-06
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclophosphamide | Other / unclassified | — | Intravenous |
| Subject | Doxorubicin | Other / unclassified | — | Intravenous |
| Subject | Etoposide | Small molecule | — | Oral |
| Subject | Mitoxantrone | Small molecule | — | Intravenous |
| Subject | prednimustine | Small molecule | — | Oral |
| Background | Didanosine | Small molecule | — | — |
| Background | Zidovudine | Small molecule | — | — |